LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Spectroscopy Solutions for Pharmaceuticals

Technical notes | 2016 | Agilent TechnologiesInstrumentation
UV–VIS spectrophotometry
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Summary

Significance of the Topic


UV-Vis spectroscopy plays a key role in pharmaceutical research, QA/QC and clinical chemistry. Adherence to USP<857> ensures reliable performance through design qualification, lifecycle management and periodic verification of instrument accuracy, precision, stray light and resolution.

Objectives and Study Overview


This white paper reviews the revised USP<857> performance criteria for UV-Vis instruments and demonstrates how the Agilent Cary 60 UV-Vis spectrophotometer with Cary WinUV software automates and simplifies compliance testing.

Methodology and Used Instrumentation


The study follows USP<857> protocols for operational qualification across four performance areas:
  • Wavelength control: accuracy and precision tests using holmium perchlorate and didymium standards
  • Absorbance control: photometric accuracy and precision tests with potassium dichromate and NIST filters
  • Stray light assessment: %T measurements at specified wavelengths using defined test solutions
  • Resolution evaluation: toluene in hexane spectrum analysis at 269 and 266 nm

Instrumentation:
  • Agilent Cary 60 UV-Vis spectrophotometer with Xenon flash lamp
  • Agilent Cary WinUV software Validate application on Windows 10

Main Results and Discussion


The Cary 60 UV-Vis consistently met USP<857> tolerances:
  • Wavelength accuracy within ±1 nm (200–400 nm) and ±2 nm (400–700 nm); precision SD < 0.5 nm
  • Photometric accuracy for UV (<1 Abs ±0.01; >1 Abs ±1%) and visible ranges with precision SD within defined limits
  • Stray light below prescribed transmission thresholds at 198, 220, 320 and 370 nm
  • Resolution ratio at 269/266 nm in line with requirements

The Cary WinUV Validate application automates data acquisition, tolerance checks and report generation, reducing manual effort and error risk.

Contributions and Practical Applications


Routine automated OQ testing enhances laboratory efficiency and data integrity. The integration of preconfigured methods and electronic records supports regulatory compliance and streamlines maintenance and troubleshooting.

Future Trends and Potential Applications


Advances may include cloud integration for remote monitoring, AI-driven anomaly detection, portable UV-Vis devices for field QC, expanded CRM libraries and enhanced software modules for seamless LIMS interaction.

Conclusion


The Agilent Cary 60 UV-Vis with Cary WinUV software offers a comprehensive, automated solution for meeting USP<857> performance requirements, ensuring accurate, precise and reliable UV-Vis measurements in pharmaceutical settings.

References


  • Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma, Agilent Technologies White Paper, Publication 5991-7268EN (2016).

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)
Application Note Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25) Meeting the requirements of the global pharmacopeias with the Agilent Cary 3500 UV-Vis Introduction UV-Vis spectroscopy is a widely used analytical technique…
Key words
absorbance, absorbancewavelength, wavelengthphotometric, photometricstray, straylight, lightpositions, positionsholmium, holmiumvis, viscontrol, controltest, testrecommended, recommendedtolerances, tolerancesreference, referencetests, testsscans
Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24
White Paper Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24 Meeting the requirements of the global pharmacopeias with the Cary 3500 UV-Vis Introduction UV-Vis spectroscopy is a widely used analytical technique in…
Key words
wavelength, wavelengthphotometric, photometricvis, visabsorbance, absorbanceoxide, oxidetests, testsdichromate, dichromateenter, enterreference, referencespectrophotometer, spectrophotometerpositions, positionsoperational, operationalprecision, precisionoptical, opticalintended
USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition
USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition Meeting requirements with the Cary 60 and Cary 3500 UV-Vis spectrophotometers Qualification of instruments Updates to the United States Pharmacopeia (USP) General Chapter <857> and the European Pharmacopoeia (Ph.…
Key words
qualification, qualificationphotometric, photometricsodium, sodiumpotassium, potassiumspectrophotometers, spectrophotometersiodide, iodidenitrate, nitratedidymium, didymiumtest, testvis, visabsorbance, absorbanceacetone, acetoneservices, serviceselectronic, electronicaccuracy
UV/Vis Pharmacopeia Performance Verification on Lunatic & Stunner
TECHNICAL NOTE UV/Vis Pharmacopeia Performance Verification on Lunatic & Stunner Introduction A Compliance with international standards for analytical testing is a must-have for drug manufacturing and quality assurance/quality control (QA/QC). The United States Pharmacopeia (USP) chapter <857> and European Pharmacopeia…
Key words
lunatic, lunaticstunner, stunnervis, vispass, passverification, verificationwavelength, wavelengthabsorbance, absorbancepharmacopeia, pharmacopeiastray, straylight, lightacceptance, acceptanceperformance, performancespectrometers, spectrometerskit, kitabsorbances
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike